全球生物电子医疗市场（2023-2030）：按类型（植入式电子医疗设备/非侵入式电子医疗设备）和最终用途（医院/其他）分類的规模、份额、成长分析和预测

Global Bioelectric Medicine Market Size, Share, Growth Analysis, By Type (Implantable electroceutical devices and non-invasive electroceutical devices), By End use(Hospitals and others) - Industry Forecast 2023-2030

出版日期: 2023年10月19日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球生物电子医疗市场规模将从2021年的201亿美元成长到2022年的212.7亿美元，预测期内年复合成长率为5.8%，预计到2030年将达到333.9亿美元。

近年来，由于医疗技术的进步和神经调节研究力度的加大，全球生物电医学市场出现了显着增长。成长是由神经系统疾病、心血管疾病和慢性疼痛等慢性疾病推动要素普及所推动的，这些疾病无法透过标准治疗方法来解决，而这些疾病正在产生未被满足的医疗需求。生物电医学为已经用尽其他选择的患者提供了一种非侵入性或微创解决方案，并显示出改善结果和生活品质的潜力。

技术进步

医疗技术的进步，包括更小的设备、更长的电池寿命、无线连接和先进的演算法，大大扩展了生物电子医学的视野。这些创新不仅提高了生物电设备和治疗的准确性和效率，还提高了其易用性，推动市场扩张。

对非侵入性治疗的需求不断增长

由于非侵入性治疗具有微创性、副作用减少以及适合家庭和门诊使用，因此对非侵入性治疗的需求不断增长，推动了生物电医学市场的成长。非侵入性电疗设备，例如 TENS 设备和 TMS 设备，正变得越来越普及，并在这一扩张中发挥关键作用。

本报告调查了全球生物电医学市场，并提供了市场概况、市场各种影响因素分析、技术和创新趋势、法律制度、市场规模趋势和预测，以及各个细分市场和地区的细分。总结了主要企业的细分、竞争形势和概况。

执行摘要
调查方法
母市场分析
- 市场概况
- 市场规模
- 市场动态
  - 促进因素
  - 机会
  - 抑制因素
  - 任务
关键市场洞察
- 技术分析
- 价格分析
- 供应链分析
- 价值链分析
- 市场生态系统
- 智慧财产权分析
- 贸易分析
- 启动分析
- 原料分析
- 创新矩阵
- 研发线产品分析
- 总体经济指标
- 重点投资分析
- 关键成功因素
- 竞争程度
- 市场动态及展望
  - 市场动态
    - 促进因素
    - 机会
    - 抑制因素
    - 任务
- 法规状况
- 波特的分析
- Skyquest 对未来颠覆的独家见解
全球生物电子医学市场：按类型
- 市场概况
- 植入式电子医疗设备
- 非侵入性电子医疗设备
全球生物电子医学市场：依最终用途分类
- 市场概况
- 医院
- 其他的
全球生物电子医学市场：按地区
- 市场概况
- 北美洲
- 欧洲
- 亚太地区
- 拉丁美洲
- 中东/非洲
竞争形势
- 前5名企业对比
- 主要企业市场地位
- 主要企业的招募策略
- 关键成功策略
- 近期市集活动
- 主要企业市场占有率
主要企业简介
- Medtronic PLC
- Abbott Laboratories
- Boston Scientific Corporation
- Nevro Corp
- electroCore LLC
- LivaNova PLC
- Inspire Medical Systems
- Second Sight Medical Products
- Soterix Medical
- NeuroMetrix
- BioControl Medical
- EnteroMedics Inc.
- MicroTransponder
- NDI Medical
- NeuroPace Inc.
- SetPoint Medical
- Galvani Bioelectronics
- Neuronetics Inc.
- Zynex Medical
- Cerbomed GmbH

简介目录

Product Code: SQMIG35G2175

Global Bioelectric Medicine Market size was valued at USD 20.1 Billion in 2021 and is poised to grow from USD 21.27 Billion in 2022 to USD 33.39 Billion by 2030, at a CAGR of 5.8% during the forecast period (2023-2030).

The global Bioelectric Medicine market has witnessed substantial growth recently, attributed to advancements in medical technology and increased research efforts in neuromodulation. Bioelectric medicine, or electroceuticals, employs electrical impulses to modulate the nervous system for therapeutic purposes, offering an innovative alternative to conventional pharmaceutical treatments. Its growth is fueled by the growing prevalence of chronic diseases, including neurological disorders, cardiovascular conditions, and chronic pain, which often resist standard therapies, resulting in unmet medical needs. Bioelectric medicine offers a non-invasive or minimally invasive solution for patients who have exhausted other options, potentially improving outcomes and quality of life. Furthermore, technological progress in bioelectric devices and implantable technologies has expanded the potential for targeted therapies.

Top-down and bottom-up approaches were used to estimate and validate the size of the global bioelectric medicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The global bioelectric medicine market is segmented on the basis of type, end use, and region. By type, the market is segmented into implantable electroceutical devices and non-invasive electroceutical devices. By end use, the market is segmented into hospitals and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers:

Technological Advancements

The evolution of medical technology, marked by the miniaturization of devices, extended battery life, wireless connectivity, and the emergence of advanced algorithms, has greatly broadened the horizons of bioelectric medicine. These innovations not only increase the precision and efficiency of bioelectric devices and treatments but also improve their user-friendliness, thus propelling market expansion.

Growing Demand for Non-Invasive Treatments

The increasing demand for non-invasive treatments, driven by their minimal invasiveness, decreased side effects, and suitability for home or outpatient use, is fueling the growth of the bioelectric medicine market. Non-invasive electroceutical devices like TENS units and TMS devices are becoming more popular and playing a key role in this expansion.

Restraints:

Stringent Regulatory Environment

Navigating the regulatory approval process for bioelectric medicine technologies can be a convoluted and protracted journey, as stringent criteria for safety, effectiveness, and quality must be met before obtaining approvals from regulatory authorities. The arduous compliance with these standards can present formidable obstacles, leading to protracted market entry timelines for innovative products in this field.

High Development and Manufacturing Costs

The substantial financial commitments required for the creation, production, and integration of bioelectric devices pose a formidable hurdle for smaller enterprises and emerging startups seeking to enter the market. The considerable expenses linked to activities such as research and development, clinical trials, and manufacturing can deter their participation in this field.

Market Trends:

The incorporation of bioelectric medicine into telemedicine and digital health solutions is broadening healthcare accessibility while enhancing patient supervision and post-treatment care. Increasingly, remote programming of implantable devices, teleconsultations, and digital platforms for patient education and support are becoming standard practices in the field of bioelectric medicine.

The field of bioelectric medicine is witnessing a substantial influx of investment and funding, with venture capital firms, government agencies, and strategic investors showing growing interest. This heightened awareness of the potential advantages of bioelectric medicine treatments is spurring financial support for research, development, clinical trials, and commercialization initiatives.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Bioelectric Medicine Market by Type
- Market Overview
- Implantable electroceutical devices and non-invasive electroceutical devices
Global Bioelectric Medicine Market by End use
- Market Overview
- Hospitals and others
Global Bioelectric Medicine Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Medtronic PLC - Ireland
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Abbott Laboratories - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Boston Scientific Corporation - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Nevro Corp - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- electroCore LLC - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- LivaNova PLC - UK
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Inspire Medical Systems - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Second Sight Medical Products - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Soterix Medical - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- NeuroMetrix - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- BioControl Medical - Israel
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- EnteroMedics Inc. - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- MicroTransponder - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- NDI Medical - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- NeuroPace Inc. - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- SetPoint Medical - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Galvani Bioelectronics - United Kingdom
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Neuronetics Inc. - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Zynex Medical - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Cerbomed GmbH - Germany
Company Overview
Business Segment Overview
Financial Updates
Key Developments